JP2007516983A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516983A5
JP2007516983A5 JP2006545846A JP2006545846A JP2007516983A5 JP 2007516983 A5 JP2007516983 A5 JP 2007516983A5 JP 2006545846 A JP2006545846 A JP 2006545846A JP 2006545846 A JP2006545846 A JP 2006545846A JP 2007516983 A5 JP2007516983 A5 JP 2007516983A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
compound
salt
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006545846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007516983A (ja
JP5384793B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2004/001830 external-priority patent/WO2005061513A1/en
Publication of JP2007516983A publication Critical patent/JP2007516983A/ja
Publication of JP2007516983A5 publication Critical patent/JP2007516983A5/ja
Application granted granted Critical
Publication of JP5384793B2 publication Critical patent/JP5384793B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006545846A 2003-12-24 2004-12-24 呼吸器合胞体ウイルス感染の処置のための多環式薬剤 Expired - Fee Related JP5384793B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003907196A AU2003907196A0 (en) 2003-12-24 Polycyclic agents for the treatment of respiratory syncytial virus infections
AU2003907196 2003-12-24
PCT/AU2004/001830 WO2005061513A1 (en) 2003-12-24 2004-12-24 Polycyclic agents for the treatment of respiratory syncytial virus infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012204388A Division JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Publications (3)

Publication Number Publication Date
JP2007516983A JP2007516983A (ja) 2007-06-28
JP2007516983A5 true JP2007516983A5 (enExample) 2008-02-07
JP5384793B2 JP5384793B2 (ja) 2014-01-08

Family

ID=34705575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006545846A Expired - Fee Related JP5384793B2 (ja) 2003-12-24 2004-12-24 呼吸器合胞体ウイルス感染の処置のための多環式薬剤
JP2012204388A Expired - Fee Related JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012204388A Expired - Fee Related JP5536842B2 (ja) 2003-12-24 2012-09-18 呼吸器合胞体ウイルス感染の処置のための多環式薬剤

Country Status (16)

Country Link
US (2) US8598193B2 (enExample)
EP (2) EP2287167A1 (enExample)
JP (2) JP5384793B2 (enExample)
KR (1) KR20060127909A (enExample)
CN (2) CN100582109C (enExample)
AT (1) ATE496920T1 (enExample)
BR (1) BRPI0418127A (enExample)
CA (1) CA2551178C (enExample)
DE (1) DE602004031258D1 (enExample)
ES (1) ES2360222T3 (enExample)
IL (1) IL176155A0 (enExample)
NO (1) NO20062758L (enExample)
NZ (1) NZ551468A (enExample)
RU (1) RU2422444C2 (enExample)
WO (1) WO2005061513A1 (enExample)
ZA (1) ZA200604528B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551178C (en) 2003-12-24 2012-11-06 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
BRPI0620066A2 (pt) * 2005-12-20 2011-11-01 Novartis Ag derivados de ácido nicotìnico como moduladores do receptor de glutamato metabotrópico, processo para preparação dos mesmos, composição farmacêutica e uso dos referidos derivados
BRPI0719122A2 (pt) 2006-08-24 2013-12-10 Novartis Ag Compostos orgânicos
MX2009003080A (es) 2006-09-22 2009-04-02 Novartis Ag Compuestos organicos heterociclicos.
TWI423972B (zh) * 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
AU2007336238A1 (en) 2006-12-20 2008-06-26 Novartis Ag 2-substituted 5-membered heterocycles as SCD inhibitors
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
AU2015200638B2 (en) * 2010-06-24 2016-11-10 Gilead Sciences, Inc. Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
CN102958933B (zh) * 2010-06-24 2016-02-03 吉里德科学公司 作为抗病毒药的吡唑并[1,5-a]嘧啶类
US8796303B2 (en) * 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
US8871756B2 (en) 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
JP2014530225A (ja) * 2011-10-11 2014-11-17 エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft 呼吸器合胞体ウイルス疾患の処置および予防のための化合物
GB201119538D0 (en) * 2011-11-10 2011-12-21 Viral Ltd Pharmaceutical compounds
ES2647486T3 (es) 2011-12-22 2017-12-21 Gilead Sciences, Inc. Pirazolo[1,5-a]pirimidinas como agentes antivirales
EA027855B1 (ru) 2012-04-17 2017-09-29 Гайлид Сайэнсиз, Инк. Соединения и способы для противовирусной терапии
CN104311559A (zh) * 2014-09-12 2015-01-28 中山大学 一类光学纯手性环状n,n-缩醛的合成方法
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2016133888A1 (en) * 2015-02-16 2016-08-25 Biota Pharmaceuticals, Inc. Compounds for treating respiratory syncytial virus infections
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
EP3298017B1 (en) 2015-05-20 2019-08-14 H. Hoffnabb-La Roche Ag Compounds for treating spinal muscular atrophy
WO2017009316A1 (en) 2015-07-16 2017-01-19 F. Hoffmann-La Roche Ag Crystalline forms of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1 -dioxido-1,4-benzothiazepin-4(5 h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections
AU2016353961B2 (en) 2015-11-12 2019-08-29 F. Hoffmann-La Roche Ag Compositions for treating spinal muscular atrophy
EP3386978B1 (en) 2015-12-10 2021-01-27 H. Hoffnabb-La Roche Ag Bridged piperidine derivatives
CA3119019C (en) 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
CA3023922C (en) * 2016-05-10 2023-04-18 Georgia State University Research Foundation, Inc. Heterocyclic derivatives for the treatment of rsv
EP4151627A1 (en) 2017-06-05 2023-03-22 PTC Therapeutics, Inc. Compounds for treating huntington's disease
JP7356911B2 (ja) 2017-06-14 2023-10-05 ヴァイロメティックス アーゲー 呼吸器合胞体ウイルスに対する予防のための環状ペプチド
CN111182898B (zh) 2017-06-28 2024-04-16 Ptc医疗公司 用于治疗亨廷顿氏病的方法
CN111163838B (zh) 2017-06-28 2023-03-28 Ptc医疗公司 用于治疗亨廷顿氏病的方法
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
CA3087926A1 (en) 2018-01-31 2019-08-08 Janssen Sciences Ireland Unlimited Company Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
US11760701B2 (en) 2018-02-27 2023-09-19 The Research Foundation For The State University Of New Yrok Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same
BR112020019373A2 (pt) 2018-03-27 2020-12-29 Ptc Therapeutics, Inc. Compostos para o tratamento da doença de hutington
AU2019260109B2 (en) 2018-04-23 2023-07-13 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV
US12157746B2 (en) 2018-06-05 2024-12-03 Hoffmann-La Roche Inc. Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease
IL279688B2 (en) 2018-06-27 2025-01-01 Ptc Therapeutics Inc Heterocyclic and heteroaryl compounds for the treatment of Huntington's disease
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
KR20210038845A (ko) 2018-06-27 2021-04-08 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료를 위한 헤테로아릴 화합물
CN108997354B (zh) * 2018-08-08 2021-12-31 青岛大学附属医院 二氢嘧啶并异吲哚酮类化合物及其乳膏剂和在治疗高尿酸血症中的用途
CA3139821A1 (en) 2019-05-13 2020-11-19 Ptc Therapeutics, Inc. Compounds for treating huntington's disease

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1058529A (en) 1910-12-24 1913-04-08 Harry T Hickey Car-door.
NL137586C (enExample) 1963-04-11
US3507863A (en) 1963-12-18 1970-04-21 Sandoz Ag Isoindolones and method for preparing same
NL126596C (enExample) 1964-02-11
CH480350A (de) 1965-09-21 1969-10-31 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
NL129866C (enExample) 1965-09-21
US3379733A (en) 1965-12-07 1968-04-23 Sandoz Ag N-(omega-aminoalkyl)isoindoles and method for preparing same
CH481124A (de) * 1966-09-21 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
DE1670041A1 (de) 1967-03-14 1972-03-02 American Home Prod Isoindole und Isoindoline
CH482697A (de) 1967-03-17 1969-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
US3885037A (en) 1968-09-05 1975-05-20 American Home Prod Method of producing anorexia using imidazolinyl phenyl carbonyl compounds, their acid addition salts and related compounds
US3935218A (en) 1968-09-05 1976-01-27 American Home Products Corporation Imidazolinyl phenyl carbonyl compounds acid addition salts and related compounds
US3657221A (en) * 1969-02-19 1972-04-18 American Home Prod Process for preparing 9b-substituted-1 - sulfonyl - 1 2 3 9b - tetrahydro-5h-imidazo(2 1-a)isoindol-5-ones
US3624101A (en) 1970-03-10 1971-11-30 American Home Prod 2,3-DIHYDRO-5-ARYL-5H-BENZ{8 f{9 IMIDAZO{8 2,1-a{9 ISOINDOL-5-OLS
US3770766A (en) 1970-03-10 1973-11-06 American Home Prod 2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones
GB1322339A (en) 1970-03-10 1973-07-04 American Home Prod Imidazoline derivatives
US3885307A (en) * 1972-05-01 1975-05-27 William A Papalardo Peeling utensil
US3966955A (en) 1974-08-07 1976-06-29 American Home Products Corporation Anti-ulcer therapy
US4056536A (en) 1976-06-29 1977-11-01 Merck & Co., Inc. Pyrrolo[2,1-b][3]benzazepines
US4258529A (en) * 1978-07-21 1981-03-31 Phillips Petroleum Company Method of sealing a container
US4701208A (en) 1983-08-02 1987-10-20 American Cyanamid Company Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) 1984-07-07 1986-02-06 Bayer Ag, 5090 Leverkusen Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de) 1984-11-16 1987-12-09 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
EP0195745B1 (de) 1985-03-12 1990-09-12 Ciba-Geigy Ag Heterocyclisch kondensierte Pyridin-Verbindungen als Herbizide
DE3534948A1 (de) * 1985-10-01 1987-04-09 Bayer Ag Fungizide und wachstumsregulatorische mittel
US4717414A (en) 1986-08-08 1988-01-05 Ppg Industries, Inc. Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
DE4103177A1 (de) 1991-02-02 1992-08-06 Boehringer Mannheim Gmbh Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel
JPH06505017A (ja) * 1991-02-28 1994-06-09 ベーリンガー マンハイム ゲーエムベーハー 三環式イソインドリノンの抗ウイルス医薬としての使用、ならびに新規な光学活性イソインドリノン
DE4108395A1 (de) 1991-03-15 1993-01-28 Boehringer Mannheim Gmbh Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten
DE4129779A1 (de) 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel
US6608098B1 (en) * 1999-08-25 2003-08-19 Banyu Pharmaceutical Co., Ltd. Isoindole derivatives
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) * 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US20040161846A1 (en) 2000-11-22 2004-08-19 Mason Anthony John Method of expression and agents identified thereby
WO2002066479A1 (en) 2001-02-23 2002-08-29 Banyu Pharmaceutical Co.,Ltd. Novel isoindole derivatives
JP2002310962A (ja) * 2001-04-19 2002-10-23 Hitachi Ltd 画像分類方法並びに観察方法及びその装置
AUPR878401A0 (en) 2001-11-09 2001-12-06 Biota Holdings Ltd Methods for identifying or screening anti-viral agents
CA2551178C (en) 2003-12-24 2012-11-06 Biota Scientific Management Pty Ltd Polycyclic agents for the treatment of respiratory syncytial virus infections
DK3187225T3 (da) 2005-04-28 2022-02-28 Viiv Healthcare Co Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑

Similar Documents

Publication Publication Date Title
RU2006126663A (ru) Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций
JP2010536887A5 (enExample)
JP2012512886A5 (enExample)
JP2006502119A5 (enExample)
SA99200059A (ar) مركبات إميدازول جديدة مستبدلة
JP2023520925A5 (enExample)
JP2007529479A (ja) マラリアの治療及び予防を意図する医薬品を調製するためのインダゾールカルボキサミド誘導体の使用
JP2012507566A5 (enExample)
CA2553269A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
JP2012532112A5 (enExample)
JP2006509749A5 (enExample)
JP2007508358A5 (enExample)
CA2554049A1 (en) Quinoline derivatives for use as mycobacterial inhibitors
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
WO2004083167A1 (ja) スルファミド誘導体及びその医薬組成物
JP2024540525A5 (enExample)
JP2019527724A5 (enExample)
JP2016508135A5 (enExample)
JP2005538111A5 (enExample)
JP2007538031A5 (enExample)
JP2005505583A5 (enExample)
AU2007302611B2 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
JP2006528667A5 (enExample)
JP2018522915A5 (enExample)
JP2020510061A5 (enExample)